These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7944344)

  • 1. DNA-hydrolyzing autoantibodies.
    Gabibov AG; Gololobov GV; Makarevich OI; Schourov DV; Chernova EA; Yadav RP
    Appl Biochem Biotechnol; 1994; 47(2-3):293-302; discussion 303. PubMed ID: 7944344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and characteristics of catalytic antibodies to DNA in systemic lupus erythematosis].
    Gololobov GV; Bogomolova AE; Iadav RP; Ermolaeva MV; Belostotskaia KM; Prokaeva TB; Shuster AM; Gabibov AG
    Biokhimiia; 1993 Feb; 58(2):313-8. PubMed ID: 8485221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study for isolation of catalytic antibodies by histidine ligand affinity chromatography as an alternative to conventional protein A/G methods.
    Nedonchelle E; Pitiot O; Vijayalakshmi MA
    Appl Biochem Biotechnol; 2000; 83(1-3):287-94; discussion 294-5, 297-313. PubMed ID: 10826967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity.
    Kozyr AV; Kolesnikov AV; Zelenova NA; Sashchenko LP; Mikhalap SV; Bulina ME; Ignatova AN; Favorov PV; Gabibov AG
    Appl Biochem Biotechnol; 2000; 83(1-3):255-68; discussion 268-9, 297-313. PubMed ID: 10826965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteolytic activity of blood serum IgG in patients with systemic lupus erythematosis].
    Kit IuIa; Mahorivs'ka IR; Havryliuk AM; Chhop'iak VV; Bilyĭ RO; Stoĭka RS
    Ukr Biokhim Zh (1999); 2009; 81(3):77-83. PubMed ID: 19877432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.
    Paul S
    Appl Biochem Biotechnol; 1994; 47(2-3):241-53; discussion 253-5. PubMed ID: 7944341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus.
    Andrievskaya OA; Buneva VN; Baranovskii AG; Gal'vita AV; Benzo ES; Naumov VA; Nevinsky GA
    Immunol Lett; 2002 May; 81(3):191-8. PubMed ID: 11947924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers.
    Kanyshkova TG; Semenov DV; Khlimankov DYu ; Buneva VN; Nevinsky GA
    FEBS Lett; 1997 Oct; 416(1):23-6. PubMed ID: 9369225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special features of the DNA-hydrolyzing activity of the antibodies in systemic lupus erythematosus.
    Nevzorova TA; Temnikov DA; Vinter VG
    Biochemistry (Mosc); 2003 Dec; 68(12):1300-6. PubMed ID: 14756625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis].
    Vlasov AV; Baranovskiĭ AG; Kanyshkova TG; Prints AV; Zabara VG; Naumov VA; Breusov AA; Giege R; Buneva VN; Nevinskiĭ GA
    Mol Biol (Mosk); 1998; 32(3):559-69. PubMed ID: 9720080
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.
    Timofeeva AM; Dmitrenok PS; Konenkova LP; Buneva VN; Nevinsky GA
    PLoS One; 2013; 8(3):e51600. PubMed ID: 23520443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-hydrolyzing autoantibodies in autoimmune pathologies.
    Schourov DV; Gololobov GV; Makarevich OI; Yadav RP; Chernova EA; Nevinsky GA; Prokaeva TB; Alekberova ZS; Gabibov AG
    Ann N Y Acad Sci; 1995 Mar; 750():255-64. PubMed ID: 7785851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interaction of catalytically active antibodies with oligoribonucleotides].
    Buneva VN; Andrievskaia OA; Romannikova IV; Gololobov GV; Iadav RP; Iamkovoĭ VI; Nevinskiĭ GA
    Mol Biol (Mosk); 1994; 28(4):738-43. PubMed ID: 7990801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity.
    Gololobov GV; Rumbley CA; Rumbley JN; Schourov DV; Makarevich OI; Gabibov AG; Voss EW; Rodkey LS
    Mol Immunol; 1997 Oct; 34(15):1083-93. PubMed ID: 9519766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA hydrolyzing autoantibodies.
    Shuster AM; Gololobov GV; Kvashuk OA; Bogomolova AE; Smirnov IV; Gabibov AG
    Science; 1992 May; 256(5057):665-7. PubMed ID: 1585181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA2-Me-pro-ChTr possessing two different activities-trypsin-like and metalloprotease.
    Timofeeva AM; Ivanisenko NV; Buneva VN; Nevinsky GA
    Int Immunol; 2015 Dec; 27(12):633-45. PubMed ID: 26174315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers.
    Semenov DV; Kanyshkova TG; Karotaeva NA; Krasnorutskii MA; Kuznetsova IA; Buneva VN; Nevinsky GA
    Med Sci Monit; 2004 Feb; 10(2):BR23-33. PubMed ID: 14737037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA-hydrolyzing IgG antibodies from the blood of patients with acquired immune deficiency syndrome].
    Odintsova ES; Kharitonova MA; Baranovskiĭ AG; Siziakina LP; Buneva VN; Nevinskiĭ GA
    Mol Biol (Mosk); 2006; 40(5):857-64. PubMed ID: 17086987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus.
    Bezuglova AM; Konenkova LP; Doronin BM; Buneva VN; Nevinsky GA
    J Mol Recognit; 2011; 24(6):960-74. PubMed ID: 22038803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis.
    Baranovskii AG; Ershova NA; Buneva VN; Kanyshkova TG; Mogelnitskii AS; Doronin BM; Boiko AN; Gusev EI; Favorova OO; Nevinsky GA
    Immunol Lett; 2001 Apr; 76(3):163-7. PubMed ID: 11306143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.